Lavelle Erin

Director at NGNE; Chief Operating Officer at ALDER BIOPHARMACEUTICALS INC

Sold, on record
$20k
Dollars the filings state
Form 4 sales
1
Latest Apr 25, 2019
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ALDER BIOPHARMACEUTICALS INCPlan not stated
    Apr 25, 2019 2019

    Sold 1,434 shares at $13.67 ($20k)

    Lavelle Erin, Chief Operating Officer

    Sold 24.5% of holdings ($80k position)4,408 shares leftFirst sale on recordFiling

  2. 2 Form 144 notice NGNENotice
    Feb 6, 2024 +1748 days

    Filed to sell 2,500 shares ($76k)

    Lavelle Erin, Director

    No 10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Lavelle Erin
Source
Feb 6, 2024Feb 6, 2024NGNEDirectorForm 144 notice2,500$76kNoticeSEC
Apr 25, 2019Apr 25, 2019ALDER BIOPHARMACEUTICALS INCChief Operating OfficerForm 4 sale1,434$20k24.5%Plan not statedSEC